In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates
Authors:
- 1 January 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 9 (suppl C) , 79-89
Abstract
The MIC and MBC of Sch 29482 (SCH), MK 0787, ceftriaxone and moxalactam were compared with each other and with cefaclor, cefamandole, cefoxitin, ticarcillin, gentamicin, and trimethoprim/sulphamethoxazole using a microdilution technique. SCH was more active than MK 0787 against Proteus mirabilis, Proteus vulgaris and Providencia spp. but less active against Streptococcus faecalis, Enterohacter cloacae, Citrobacter freundii and Acinetobacter spp. Pseudomonas aeruginosa was very sensitive to MK 0787 (MIC 90 =2 mg/l) but resistant to SCH (MIC 10 =mg/l). Ro 13–9904 was more active than either SCH or MK 0787 against Ent. cloacae, Serratia marcescens, Providencia spp. and Pr. mirahilis but activity varied against several other Gram-negative species, especially Ps. aeruginosa . Ceftriaxone was less active than either SCH or MK 0787 against the staphylococci. Ceftriaxone was generally more active than moxalactam against Gram-positive bacteria but was equally or less active against members of the Bacteroides fragilis group (MIC 90 =mg/l). Ceftriaxone was less active than SCH, MK 0787 and moxalactam against these strains. Most MBC values were within one doubling dilution of the MIC. This was true for both SCH and MK 0787 against Sir.faecalis. We conclude that SCH, MK 0787, ceftriaxone and moxalactam are highly active, broad-spectrum antimicrobials in vitro which have a remarkably wide range of coverage.Keywords
This publication has 12 references indexed in Scilit:
- Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporinAntimicrobial Agents and Chemotherapy, 1981
- In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidimeAntimicrobial Agents and Chemotherapy, 1981
- In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistanceAntimicrobial Agents and Chemotherapy, 1981
- Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studiesAntimicrobial Agents and Chemotherapy, 1980
- In vitro evaluation of Ro 13-9904Antimicrobial Agents and Chemotherapy, 1980
- Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilliAntimicrobial Agents and Chemotherapy, 1980
- In vitro activity of N-formimidoyl thienamycin (MK0787)Antimicrobial Agents and Chemotherapy, 1980
- Ro 13–9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an in vitro comparative studyJournal of Antimicrobial Chemotherapy, 1980
- MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activitiesAntimicrobial Agents and Chemotherapy, 1980
- Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979